On October 29, 2026, Everyday Health published an explainer syndicated by Yahoo Health on how menopause hot flashes and night sweats may affect sleep and intimacy. The American College of Obstetricians and Gynecologists (ACOG) had announced expanded guidance on vasomotor symptoms (VMS), sleep and mood on October 15, 2026.
The update broadens care rather than replacing hormone therapy
Hormone therapy remains an option in the clinical care ACOG describes. The update provides more detail on hormonal and nonhormonal approaches rather than replacing one standard treatment with another. ACOG President Camille A. Clare also described menopause as a normal life stage that does not require enduring disruptive symptoms without help.
That is the practical distinction: recognizing menopause as normal need not mean leaving its effects on daily life unaddressed. It supports matching care to the symptoms that matter rather than assuming everyone needs the same response.
The findings connect symptoms with the life around them
The Everyday Health article is an explainer rather than a new treatment trial. Its links between VMS and intimacy describe possible experiences, not an inevitable sequence or proof that symptoms explain every relationship difficulty. The survey findings below apply to their reported participants rather than all women. Comfort measures and treatment options are different responses to specific problems, not a package proven to restore desire.
Sleep disruption can carry into the next day
- VMS are hot flashes and night sweats. The Everyday Health explainer says they affect up to 80% of women going through menopause. Its focus is not just heat: it describes effects on sleep and mood alongside work and intimacy. For a woman trying to make sense of feeling less available for closeness, that broader view creates room to describe the whole experience rather than discussing each concern in isolation.
- Interrupted sleep is one possible connecting thread. The explainer describes brief awakenings caused by hot flashes or night sweats. Poor sleep can contribute to irritability and stress. It also describes anxious or low feelings, while stress may worsen symptoms for some people.
That is a reason to include night-time symptoms and emotional wellbeing in the same conversation. A description of both the night and the following day gives the discussion more context.
- Daytime effects deserve space too. A separate Yahoo Health article reports that, in a survey of 619 women, 91% said menopause symptoms affected their sleep. Among that group, 83% said the sleep effects affected daytime productivity. These results concern menopause symptoms overall rather than VMS alone.
They put the daytime experience into the picture when discussing a concern that may first be noticed in bed. The same Yahoo Health article summarizes another study involving 4,440 women. Nearly 11% had missed work because of symptoms. Work effects belong in a menopause conversation alongside difficulties at home, rather than being treated as an unrelated part of the day.
Work is one setting for the impact, not the measure of whether a woman's discomfort deserves attention. The sleep and intimacy concerns described in the October 29 explainer matter in their own right.
Closeness and sleeping comfort are separate concerns
- Reduced sexual interest has a context. The Everyday Health explainer links less interest in sex or other intimacy with tiredness and irritability. It also describes stress and feeling sweaty or disconnected. The practical point is to distinguish wanting less intimacy from finding the circumstances around intimacy uncomfortable.
That distinction matters when talking about changes in desire during midlife.
- A shared bed can present a heat problem. The explainer notes that a partner's body heat may make bed-sharing less comfortable. It suggests cooling the bedroom and directing a fan toward one's own side of the bed. Breathable bedding and sleepwear are other options it names.
These suggestions target the sleeping environment. They can sit alongside a discussion about closeness without asking a bedroom adjustment to answer every question about sex.
Partner communication makes symptoms part of the conversation
- Information is the starting point. Susan E. Loeb-Zeitlin is an obstetrician-gynecologist and director of Weill Cornell Medicine's Women's Midlife Center. In the Everyday Health article, she advises keeping a partner informed about what menopause symptoms involve. The discussion can name the problem directly: disrupted sleep or feeling uncomfortably hot when sharing a bed.
This keeps attention on the experience being described. It also leaves room to talk about intimacy without presenting lower interest as something a woman must immediately correct.
- Patterns can help make the account specific. Loeb-Zeitlin recommends tracking possible symptom triggers and mood changes for discussion with a clinician. The practical focus is on what is happening in daily life rather than arriving with a ready-made explanation. Sleep and mood belong in that account alongside intimate comfort.
The explainer advises professional care when symptoms are disruptive. Describing their effect on ordinary life gives that conversation a clear starting point.
Dryness relief and desire are different treatment goals
- Lubricants and moisturizers address a particular kind of discomfort. The Everyday Health explainer names water-based or silicone-based lubricant and vaginal moisturizer as options for dryness-related discomfort. That is a different purpose from treating hot flashes or addressing lower desire. The useful question is which problem an option is meant to address.
Keeping these goals separate makes the conversation about pain or discomfort during intimacy more precise. Sexual comfort deserves attention in its own right rather than only as a route toward more sex.
- Persistent discomfort belongs in an individual care discussion. The explainer says vaginal estrogen may be considered when nonhormonal aids have not helped. It presents this as an issue for a clinician, not a reason to select a treatment from an article. A conversation about dryness can sit alongside one about night sweats without assuming both concerns need the same response.
The decision should stay connected to the symptom being addressed and the woman's priorities.
Expanded guidance includes medication and nonmedication options
- Hormone-therapy decisions remain individual. ACOG calls for shared decision-making that accounts for symptoms and age. Medical history and baseline cardiovascular risk are part of that assessment. Breast-cancer risk and blood-clot risk also matter, together with the patient's goals and priorities.
This places the decision with the woman and her clinician. The relevant outcome may include how symptoms interfere with sleep or daily life rather than an expectation that everyone needs the same care.
- Nonhormonal care has a place in the guidance. ACOG discusses SSRIs and SNRIs alongside neurokinin receptor antagonists such as fezolinetant and elinzanetant. It also addresses cognitive behavioral therapy and mindfulness-based interventions. Exercise, clinical hypnosis and acupuncture appear in its discussion of nonpharmacologic approaches.
A clinician can relate that wider discussion to the symptoms and priorities a woman brings to the appointment.
- Supplements should not borrow credibility from the broader update. ACOG says evidence does not support phytoestrogens or herbal supplements as safe and effective treatments for menopausal symptoms. Its discussion of nonhormonal care is not an endorsement of every product marketed for menopause. Being sold as a menopause product is different from being supported by the guidance.
The practical focus remains identifying the problem and discussing evidence-based options with a qualified clinician.
Daily-life priorities belong in the care plan
- The starting point is the effect on daily life. The practical takeaway from the explainer and ACOG's guidance is to identify which symptoms are affecting sleep or mood. Intimacy and work effects also belong in that description. This is more specific than asking whether menopause is simply something to put up with.
A useful discussion separates the concern from the hoped-for outcome. Less interrupted sleep is one goal; more comfortable intimacy is another. Naming the outcome gives shared decision-making something concrete to address.
- Personal circumstances belong beside clinical risks. Catherine D. Cansino, an author of ACOG's guidance, says racial and cultural factors can affect menopause experiences and access to care. Socioeconomic factors also shape that picture. This broadens the conversation beyond which treatment exists to whether appropriate care is accessible.
The editorial implication is that disruptive symptoms should be heard in the context of a woman's life. Recognizing menopause as normal and taking its effects seriously are compatible positions. Neither requires reducing her to a collection of symptoms.
Future care should take intimate comfort seriously
Together, the explainer and ACOG's expanded guidance point toward menopause care that treats sleep and intimate comfort as part of symptom assessment and shared treatment decisions.
How Refemina helps
Fewer disrupted nights and more comfortable intimacy are meaningful goals; Refemina explains how hormonal change relates to sexual wellbeing and confidence. For readers left with silence or sensational claims about sex in midlife, the publication offers clear context for changing bodies while treating intimate confidence as a legitimate part of health.
Explore Resources
Sources
- Menopause vasomotor symptoms impact daily
- ACOG Expands Recommendations for Management of Menopause Symptoms
- Why You Shouldn't Put Up With Hot Flashes in Menopause
